These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 24477679)

  • 1. Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010.
    Wisløff T; Hagen G; Hamidi V; Movik E; Klemp M; Olsen JA
    Pharmacoeconomics; 2014 Apr; 32(4):367-75. PubMed ID: 24477679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?
    Barton GR; Sach TH; Jenkinson C; Avery AJ; Doherty M; Muir KR
    Health Qual Life Outcomes; 2008 Jul; 6():51. PubMed ID: 18625052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The remarkably frequent use of EQ-5D in non-economic research.
    Wang A; Rand K; Yang Z; Brooks R; Busschbach J
    Eur J Health Econ; 2022 Aug; 23(6):1007-1014. PubMed ID: 34846623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO study.
    Knapp M; Windmeijer F; Brown J; Kontodimas S; Tzivelekis S; Haro JM; Ratcliffe M; Hong J; Novick D;
    Pharmacoeconomics; 2008; 26(4):341-58. PubMed ID: 18370568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Life Gain After Septorhinoplasty: An Analysis of Health Utility and Cost Utility Values Associated with Septorhinoplasty.
    Oladokun D; Baumgart A; Baumann I; Bulut OC
    Aesthetic Plast Surg; 2018 Dec; 42(6):1618-1624. PubMed ID: 30251221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002-4.
    Scuffham PA; Whitty JA; Mitchell A; Viney R
    Pharmacoeconomics; 2008; 26(4):297-310. PubMed ID: 18370565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost-utility analyses.
    Rankin J; Rowen D; Howe A; Cleland JGF; Whitty JA
    Heart Fail Rev; 2019 Jul; 24(4):549-563. PubMed ID: 30903357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological Issues Surrounding the Use of Baseline Health-Related Quality of Life Data to Inform Trial-Based Economic Evaluations of Interventions Within Emergency and Critical Care Settings: A Systematic Literature Review.
    Dritsaki M; Achana F; Mason J; Petrou S
    Pharmacoeconomics; 2017 May; 35(5):501-515. PubMed ID: 28063084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
    Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
    Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions.
    Davis JC; Liu-Ambrose T; Khan KM; Robertson MC; Marra CA
    Osteoporos Int; 2012 Jul; 23(7):1849-57. PubMed ID: 21909728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
    Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G
    Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using qualitative methods to inform the trade-off between content validity and consistency in utility assessment: the example of type 2 diabetes and Alzheimer's disease.
    McGrath C; Rofail D; Gargon E; Abetz L
    Health Qual Life Outcomes; 2010 Feb; 8():23. PubMed ID: 20152041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project.
    Beresniak A; Medina-Lara A; Auray JP; De Wever A; Praet JC; Tarricone R; Torbica A; Dupont D; Lamure M; Duru G
    Pharmacoeconomics; 2015 Jan; 33(1):61-9. PubMed ID: 25230587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using QALYs in telehealth evaluations: a systematic review of methodology and transparency.
    Bergmo TS
    BMC Health Serv Res; 2014 Aug; 14():332. PubMed ID: 25086443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.
    Brown GC; Brown MM; Lieske HB; Lieske PA; Brown KS; Lane SS
    Ophthalmology; 2011 Sep; 118(9):1834-43. PubMed ID: 21723614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping to obtain EQ-5D utility values for use in NICE health technology assessments.
    Longworth L; Rowen D
    Value Health; 2013; 16(1):202-10. PubMed ID: 23337232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.